# YSPSL for Prevention of Delayed Graft Function Part A

> **NCT00298181** · — · COMPLETED · sponsor: **Y's Therapeutics, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Delayed Graft Function

## Interventions

- **DRUG:** YSPSL

## Key facts

- **NCT ID:** NCT00298181
- **Lead sponsor:** Y's Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2006-11
- **Final completion:** 2007-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2008-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00298181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00298181, "YSPSL for Prevention of Delayed Graft Function Part A". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00298181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*